At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental weight-loss pill to treat obesity in development called amycretin. And it may boast substantial weight loss results comparable to those of popular GLP-1 injectables like Ozempic and Wegovy (both of which were created by the same company).

Results showed that children treated with Saxenda reduced their Body Mass Index (BMI) by 5.8%, while the control group saw only a 1.6% reduction.

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and there are fewer restrictions around the timing of the dose than pills. They’re typically only taken once per week, which may be an easier schedule to stick to, especially for people who don’t take many medications regularly.

Daily” pill is the latest product to capitalize on the weight loss drug craze. By Dani Blum There’s a long list of products that companies and influencers claim can deliver quick and dramatic weight loss,

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal body weight,” with his cholesterol below 200 for the first time in 20 years.

Amycretin, an oral weight loss pill developed by the makers of Wegovy, led to a 13.1% weight loss over three months in early trial results.